TRAVA Review

TRAVA — Provider Profile

Overview

TRAVA is a cash-pay telehealth platform focused on compounded GLP-1 injectable medications, operating at taketrava.com. The platform is built around a single value proposition: the lowest entry price for compounded semaglutide in the market, bundled with free next-day air shipping and no membership fees.

TRAVA uses an async consultation model in most states — patients submit an online intake form, a licensed provider reviews it through a patient portal, and medication ships from a partner compounding pharmacy. The async structure keeps overhead low, which is reflected in the $119.96/mo starting price. Multiple pharmacy partnerships are used for supply resilience.

The tradeoff for the low entry price is that costs rise at higher semaglutide doses, and a subset of patients has reported support and billing issues as the company scaled. Reviews on Trustpilot are polarized: 59% five-star, 24% one-star, with an overall 3.8/5 rating.

April 2026 context: TRAVA uses compounded semaglutide and tirzepatide. These are not FDA-approved medications — they are prepared by state-licensed 503A compounding pharmacies under individual prescriptions. The FDA has taken enforcement action against compounders in this space and is actively maintaining pressure on the sector. Supply from compliant pharmacies remains available, but the regulatory environment is unstable. Patients should factor this in when evaluating any compounded GLP-1 provider.

Medications Offered

• Compounded semaglutide + B12 injectable — Not FDA-approved; B12 included in formulation at all dose levels
• Compounded tirzepatide + B12 injectable — Not FDA-approved; B12 included in formulation at all dose levels
• No brand-name options available

Pricing

Pricing is all-inclusive: telehealth consultation, medication, B12, supplies, and free next-day air shipping. No membership fee and no separate consultation fee. Pricing increases at higher semaglutide doses — the $119.96/mo rate applies at starting doses. Patients who titrate up should expect higher monthly costs.

States Served

Available in approximately all 50 states. State-specific availability may vary; confirm at checkout.

Insurance

Cash-pay only. No insurance accepted. No consultation fee or membership fee billed separately.

Consultation Process

Model: Async — no video consultation required for most states.

1. Complete an online intake questionnaire covering health history, current medications, and weight loss history
2. A licensed provider reviews the intake through a patient portal — communication is primarily via messaging, not live video
3. If approved, a prescription is routed to a partner compounding pharmacy
4. Medication ships with free next-day air delivery

Ongoing access to provider messaging for dose adjustments and side effect questions.

Pros

• Lowest entry price for compounded semaglutide among major providers ($119.96/mo)
• Free next-day air shipping on all orders
• B12 included in both semaglutide and tirzepatide formulations
• No membership fee or separate consultation charge
• Bundled, transparent pricing
• Multiple pharmacy partnerships for supply availability

Cons

• Price increases significantly at higher semaglutide doses — the low entry price does not hold through titration
• Customer support complaints surfaced in mid-2025 reviews, including response delays at scale
• Documented billing complaints and reports of unauthorized charges in customer reviews
• Trustpilot reviews are polarized (3.8/5 overall; 59% five-star, 24% one-star)
• Binding arbitration clause with a 30-day opt-out window
• No refunds on partially used billing periods
• No brand-name medication pathway
• Compounded medications not FDA-approved; subject to active regulatory enforcement pressure

Best For

Budget-conscious patients starting at lower semaglutide doses who want the lowest possible entry price. TRAVA's $119.96/mo starting rate is the most competitive in the market at initiation doses.

Not ideal for: Patients who anticipate titrating to higher doses (cost escalates substantially), patients who need responsive customer support, or patients with billing or charge sensitivity. If predictable pricing at higher doses is a priority, compare Eden Health (flat pricing) or Ness Healthcare (flat fee regardless of dose).

Editorial Verdict

TRAVA leads on entry price. For a patient starting compounded semaglutide at the lowest titration dose, $119.96/mo with free next-day shipping and no fees is difficult to beat. The B12 inclusion adds marginal value, and the multi-pharmacy model is a practical hedge against supply disruptions.

The pricing structure works against patients who titrate — TRAVA's low headline rate becomes less competitive as dose increases. The review pattern on Trustpilot (highly polarized, not just mixed) points to an inconsistent support experience rather than a uniformly mediocre one: patients either have a smooth experience or a difficult one. Billing complaints and the arbitration clause deserve attention before signing up.

TRAVA belongs on the shortlist for patients prioritizing lowest upfront cost who plan to start slow and evaluate before committing to higher doses. It is a less good fit for patients who know from the outset that they need to titrate aggressively.

Bottom line as of April 2026: TRAVA wins on entry price. If you plan to stay at lower doses or want to test compounded semaglutide before committing to a higher-cost protocol, it belongs on the shortlist. Review the billing terms carefully and compare total cost at your anticipated therapeutic dose before choosing.

Related Content

• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• GLP-1 Compounding Pharmacies: What Patients Need to Know — Full regulatory context
• GLP-1 Cost & Insurance FAQ — What you'll actually pay